Technical Analysis for ATNM - Actinium Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 7.83 17.22% 1.15
ATNM closed up 17.22 percent on Friday, September 17, 2021, on 4.02 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical ATNM trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Older End-of-Day Signals for ATNM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot 1 day ago
Up 2 ATRs 1 day ago
Up 10% 1 day ago
Rose Above Previous Day's High 1 day ago
Up 5% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Actinium Pharmaceuticals, Inc. Description

Actinium Pharmaceuticals, Inc., formerly Cactus Ventures, Inc. is a biopharmaceutical company developing cancer drugs. The Company's advanced products are Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), in human clinical trials for acute myeloid leukemia (AML) and Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center (MSKCC), a related institution. The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunology Immunotherapy Natural Sciences Antibodies Monoclonal Antibody Chemical Elements Monoclonal Antibodies Stem Cells Acute Myeloid Leukemia Transplantation Platform Technology Cancer Center Hematopoietic Stem Cell Actinides Bismuth Iodine Cactus Immunotherapy Technology Kettering Cancer Center Memorial Sloan

Is ATNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 13.18
52 Week Low 5.72
Average Volume 189,633
200-Day Moving Average 8.02
50-Day Moving Average 6.58
20-Day Moving Average 6.25
10-Day Moving Average 6.37
Average True Range 0.41
ADX 19.65
+DI 36.32
-DI 12.13
Chandelier Exit (Long, 3 ATRs) 6.61
Chandelier Exit (Short, 3 ATRs) 6.96
Upper Bollinger Bands 7.12
Lower Bollinger Band 5.38
Percent B (%b) 1.41
BandWidth 27.93
MACD Line 0.07
MACD Signal Line -0.11
MACD Histogram 0.175
Fundamentals Value
Market Cap 106.38 Million
Num Shares 13.6 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -41.65
Price-to-Sales 0.00
Price-to-Book 3.11
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.68
Resistance 3 (R3) 9.48 8.66 9.37
Resistance 2 (R2) 8.66 8.19 8.76 9.26
Resistance 1 (R1) 8.25 7.90 8.46 8.45 9.16
Pivot Point 7.43 7.43 7.54 7.53 7.43
Support 1 (S1) 7.02 6.96 7.23 7.22 6.50
Support 2 (S2) 6.20 6.67 6.30 6.40
Support 3 (S3) 5.79 6.20 6.29
Support 4 (S4) 5.99